Thyroid Cancer Causes
Thyroid Cancer Causes
Two causes are established: childhood radiation exposure and inherited RET mutations. Everything else — age, sex, iodine, thyroiditis — shifts probability rather than determining it, and the rising incidence is mostly increased detection.
Age and sex: the strongest patterns
Thyroid cancer is roughly three times commoner in women than in men, and this ratio is one of the most consistent findings in the epidemiology of the disease. The reason is not settled. Oestrogen receptors are present on thyroid cells, pregnancy and the postpartum period are recognised times of nodule development, and there is a probable interaction with autoimmune thyroid disease — but no single mechanism explains the pattern, and it is honest to present it as an association rather than a cause.
Age behaves differently from most cancers. Differentiated thyroid cancer is unusual in peaking in the thirties and forties rather than in later life, and it is one of the few cancers where a younger age at diagnosis is a favourable rather than an adverse factor — so much so that the staging system treats age 55 as a boundary. The aggressive types break the pattern: anaplastic carcinoma occurs almost entirely in patients over 60.
Ionising radiation: the clearest established cause
Exposure of the head and neck to ionising radiation during childhood or adolescence is the best-established environmental cause of thyroid cancer. The evidence comes from several directions: the elevated incidence of papillary carcinoma in populations exposed to fallout after the Chernobyl accident, in those who received therapeutic radiation to the neck for benign conditions decades ago, and in survivors of childhood cancer treated with radiation that included the neck.
Two qualifications matter for anyone reading this with concern. First, the risk falls sharply with age at exposure — radiation received after adolescence carries far less thyroid risk. Second, diagnostic imaging is not the same as therapeutic radiation: a dental radiograph or a chest X-ray delivers orders of magnitude less than the doses in those studies. Even so, the principle of using imaging only when it changes management applies with particular force to the neck in children, and it is the reason thyroid surveillance is part of long-term follow-up after childhood radiotherapy.
Inherited risk and the RET gene
Most thyroid cancer is not inherited, but one type is inherited often enough that it changes how families are managed. Around a quarter of medullary carcinoma cases arise from a germline RET mutation as part of multiple endocrine neoplasia type 2 — MEN2A, MEN2B, or familial medullary thyroid carcinoma. Because the mutation is present from birth and the disease is virtually certain to develop, carriers are offered prophylactic thyroidectomy at an age determined by the specific mutation, and family testing is part of standard care.
For the differentiated cancers, inheritance is weaker and less well defined. A first-degree relative with papillary carcinoma raises the risk modestly, and a small proportion of papillary carcinoma occurs in familial clusters whose genetic basis is still being worked out. Some of those families also carry an increased risk of other tumours, including colorectal and renal cancer. The practical implication is limited but real: if two or more close relatives have had thyroid cancer, the family history belongs in the medical record, and relatives should mention it when a neck lump is assessed.
Iodine: deficiency, excess and the type of cancer
Iodine is the raw material of thyroid hormone, and the relationship between iodine intake and thyroid cancer is more subtle than it is usually presented. Iodine deficiency is associated with follicular carcinoma and with the follicular-patterned cancers, which is part of why follicular carcinoma is relatively commoner in regions where goitre was once endemic. Iodine deficiency is not, however, a major cause of papillary carcinoma.
Where iodine intake has been increased through salt iodisation, the pattern of disease has shifted: follicular carcinoma has become less common and papillary carcinoma more so. That shift reflects a change in the type of cancer rather than a clear rise in overall risk, and it is the main reason the relationship is described as an influence on cancer type rather than as a cause of cancer. Taking iodine supplements does not prevent thyroid cancer, and there is no evidence that it reduces the risk of any type.
Hashimoto's thyroiditis and other thyroid conditions
Hashimoto's thyroiditis is an autoimmune condition in which the immune system attacks the thyroid, leaving it firm, enlarged and often underactive. It is common, it is far commoner in women, and it coexists with papillary carcinoma more often than chance would explain. Whether it actually causes the cancer is still debated: chronic inflammation and the constant cell turnover it drives are plausible mechanisms, and the association is consistently observed, but the effect on risk for any individual patient is modest.
The more useful point is practical. Hashimoto's makes the gland lumpy, which can mask a nodule on examination, and it is a reason to characterise any dominant nodule on ultrasound rather than attributing it to thyroiditis. The condition itself does not need surgery, and a raised antibody level on a blood test does not mean a nodule is malignant.
Other factors worth knowing about
A number of additional associations appear in the literature, and they are worth stating accurately — as associations of modest size, not as causes:
- Benign thyroid nodules — most never become cancerous, but a nodule is a reason for structured follow-up rather than a diagnosis in itself.
- Thyroid surgery for a benign condition, particularly decades earlier, is associated with a small increase in risk in some series.
- Obesity has been associated with a modest increase in thyroid cancer risk in large cohort studies, as it has with several other cancers.
- Other thyroid cancer syndromes — Cowden syndrome, familial adenomatous polyposis and Carney complex carry an elevated risk of thyroid cancer, and surveillance is part of managing those conditions.
- Wealth and healthcare access correlate with incidence, which is a signal about detection rather than about biology.
Four things that are not causes
Several widely repeated beliefs about thyroid cancer are not supported by the evidence, and clearing them up is more useful than listing one more speculative risk:
- Blood tests that are abnormal do not indicate cancer. A high or low TSH shows a hormone problem, not a malignancy; thyroid cancer usually leaves function entirely normal.
- Fine-needle aspiration does not spread the cancer. Needle-track seeding is negligible in reported practice, and biopsy remains the standard diagnostic step.
- Stress is not an established cause. Chronic stress affects many aspects of health, but there is no reliable evidence that it causes thyroid cancer, and attributing a diagnosis to stress costs patients the ability to make decisions about real risk factors.
- A cell phone held to the ear is not a demonstrated cause. The evidence on radiofrequency exposure and thyroid cancer is inconsistent, and current assessments do not support it as a risk factor.
What to do with this information
For most people the actionable part of this page is small: a history of childhood neck radiotherapy is worth recording and acting on; a family history of medullary carcinoma is worth genetic counselling; and a nodule with suspicious features is worth investigating regardless of how the risk factors read. Everything else is probability, and probability is not something an individual can act on directly.
If you have a nodule, the useful next step is an ultrasound-based risk assessment rather than a review of risk factors — and our team can perform that assessment on images taken elsewhere. If you have a family history of medullary carcinoma, the next step is genetic counselling and, where a mutation is found, testing of relatives. Both are decisions that become clearer with a specific finding, which is what the prevention and follow-up page sets out.